Overview

Pharmacokinetic and Safety Study of SPARC1023 Alone and in Carboplatin Combination

Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
Phase I study of SPARC1023 alone and in combination with carboplatin
Phase:
Phase 1
Details
Lead Sponsor:
Sun Pharma Advanced Research Company Limited